Available online at ajdhs.com

Asian Journal of Dental and Health Sciences

Open Access to Dental and Medical Research

Copyright  © 2025 The  Author(s): This is an open-access article distributed under the terms of the CC BY-NC 4.0 which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use provided the original author and source are credited

 

Nitrogen Balance and Its Impact on Hematological Function in Sickle Cell Patients: A Review

* Emmanuel Ifeanyi Obeagu 

Department of Biomedical and Laboratory Science, Africa University, Zimbabwe.

 

 

Introduction

Sickle cell disease (SCD) is an inherited hemoglobinopathy characterized by the presence of sickle-shaped erythrocytes due to a mutation in the β-globin gene, resulting in the production of abnormal hemoglobin S (HbS). This structural abnormality leads to red blood cell deformation under deoxygenated conditions, causing vaso-occlusion, chronic hemolytic anemia, and multi-organ complications. SCD predominantly affects individuals of African, Middle Eastern, and Mediterranean descent, and despite advances in treatment, it remains a major contributor to morbidity and mortality in affected populations. Nutritional deficiencies, though often under-recognized, significantly impact the clinical course of SCD ^1-6. One of the less explored but highly relevant aspects of nutritional status in SCD is nitrogen balance. Nitrogen, a fundamental component of amino acids and nucleotides, is vital for cellular function, growth, and repair. Nitrogen balance refers to the net difference between nitrogen intake—primarily through dietary protein—and nitrogen loss via urine, feces, sweat, and other bodily excretions. A positive nitrogen balance is indicative of anabolic states such as growth, recovery, or pregnancy, whereas a negative nitrogen balance denotes catabolism and potential physiological deterioration ^7-8.

Patients with SCD are particularly susceptible to a negative nitrogen balance due to several interrelated factors. Chronic hemolysis increases the demand for erythropoiesis, which in turn escalates the requirement for amino acids and other nutrients necessary for red blood cell synthesis. Additionally, recurring infections, systemic inflammation, oxidative stress, and frequent hospitalizations contribute to hypermetabolism and increased protein turnover. These factors collectively shift the metabolic equilibrium toward a catabolic state, exacerbating nitrogen loss and depleting protein reserves critical for hematological function ^9-11. The implications of a disrupted nitrogen balance in SCD extend beyond basic nutrition. Inadequate protein availability may hinder the synthesis of hemoglobin, reduce erythrocyte lifespan, and impair bone marrow function. This can lead to worsened anemia, decreased immune response, and slower recovery from vaso-occlusive crises or other complications. Moreover, in pediatric populations, persistent nitrogen imbalance is associated with growth retardation, delayed sexual maturation, and poor neurocognitive development, further underscoring the systemic consequences of poor nitrogen homeostasis ^12-15.

 

 

Understanding Nitrogen Balance

Nitrogen balance is a fundamental concept in clinical nutrition and physiology, serving as a marker of protein metabolism and overall nutritional status. It represents the equilibrium between nitrogen intake—largely derived from dietary proteins—and nitrogen excretion, which occurs primarily through urine in the form of urea, but also through feces, sweat, skin desquamation, and other minor losses. A positive nitrogen balance indicates an anabolic state, where nitrogen intake exceeds loss, supporting growth, tissue repair, and recovery. In contrast, a negative nitrogen balance suggests a catabolic state, where nitrogen losses exceed intake, reflecting protein degradation and inadequate nutritional support ¹⁶. In healthy individuals, nitrogen balance fluctuates depending on physiological demands such as growth (e.g., childhood, adolescence), pregnancy, illness, or post-surgical recovery. The body requires a constant supply of amino acids not only for structural proteins but also for enzymes, hormones, immunoglobulins, and hemoglobin. When dietary protein intake is insufficient or when metabolic demands are increased—as seen in chronic diseases like sickle cell disease—the body begins to catabolize its own proteins, leading to muscle wasting, immunosuppression, and impaired erythropoiesis ¹⁷.

Measurement of nitrogen balance is typically performed through dietary assessment and analysis of nitrogen excretion, most commonly via 24-hour urinary urea nitrogen (UUN). The calculation takes into account estimated non-urinary nitrogen losses and helps clinicians evaluate whether a patient is receiving adequate protein. However, in settings like SCD, where inflammation and oxidative stress alter metabolism, interpreting nitrogen balance becomes more complex. It is crucial to consider the disease-specific context, as SCD patients may exhibit elevated basal metabolic rates and protein turnover even in clinically stable states, thereby necessitating higher protein intake to achieve nitrogen equilibrium ¹⁸. In SCD, maintaining nitrogen balance is particularly challenging due to persistent hemolysis, increased erythropoietic activity, and frequent inflammatory episodes. Each of these processes imposes a substantial demand on amino acid pools, making protein sufficiency a prerequisite for adequate hematological function. Furthermore, nitrogen balance is intimately linked to overall clinical outcomes in SCD—negative nitrogen states are associated with increased fatigue, reduced hemoglobin levels, higher susceptibility to infections, and longer recovery periods from vaso-occlusive crises ¹⁸.

Nitrogen Metabolism in Sickle Cell Disease

Nitrogen metabolism plays a pivotal role in maintaining physiological homeostasis, particularly in conditions marked by chronic inflammation, increased cellular turnover, and heightened metabolic demand—hallmarks of sickle cell disease (SCD). In individuals with SCD, the pathophysiology of the disease imposes a substantial burden on protein metabolism due to the continuous need for erythrocyte regeneration, tissue repair, and immune function support. These processes necessitate a constant and elevated supply of amino acids, making nitrogen metabolism a critical determinant of health outcomes in this population ^19-20. One of the primary contributors to altered nitrogen metabolism in SCD is the state of chronic hemolysis. Hemolysis not only leads to anemia and reduced oxygen-carrying capacity but also accelerates the turnover of erythrocytes, thereby increasing the demand for protein synthesis to replenish red blood cells. This continuous erythropoietic drive consumes large amounts of nitrogen in the form of amino acids necessary for hemoglobin and cellular component production. Inadequate dietary protein or inefficient utilization of nitrogen can thus lead to a deficit, resulting in negative nitrogen balance and its attendant complications ²¹.

In addition to hemolysis, recurrent infections and vaso-occlusive crises in SCD further compound nitrogen losses through systemic inflammation and catabolic stress. During these episodes, pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) stimulate protein breakdown in muscle tissue, divert amino acids away from constructive processes like hematopoiesis, and increase urinary nitrogen excretion. Fever, tissue damage, and organ dysfunction may also impair nutrient absorption and utilization, making it more difficult to maintain a favorable nitrogen status ^22-23. The metabolic adaptations observed in SCD, including elevated resting energy expenditure and increased protein turnover, also affect nitrogen utilization. Several studies have documented higher caloric and protein needs in children and adults with SCD compared to healthy controls, even during periods of clinical stability. However, standard nutritional guidelines often fail to reflect these heightened requirements, leading to chronic undernutrition and suboptimal nitrogen retention. This discrepancy contributes to poor growth, delayed puberty, and reduced resilience against oxidative and infectious insults ^24-25 From a biochemical perspective, disruptions in nitrogen metabolism in SCD also affect other physiological systems, including the urea cycle, amino acid synthesis, and nitric oxide (NO) production. Arginine, a semi-essential amino acid and a key component of nitrogen metabolism, is often depleted in SCD due to increased consumption in hemolysis and inflammation. Arginine deficiency can impair NO synthesis, contributing to endothelial dysfunction and worsening vaso-occlusive phenomena. These intricate interplays highlight how nitrogen metabolism extends beyond nutritional status, directly influencing vascular tone and hematologic stability in SCD ²⁶.

Hematological Implications of Nitrogen Imbalance

Nitrogen imbalance in individuals with sickle cell disease (SCD) is not merely a nutritional concern; it has direct and far-reaching hematological implications. The continuous loss of nitrogen, when not matched by adequate dietary intake, disrupts protein homeostasis and undermines essential physiological processes involved in hematopoiesis. This imbalance contributes significantly to the severity of anemia, immune dysfunction, and delayed recovery from hematologic insults commonly encountered in SCD ²⁰. Hemoglobin synthesis is one of the most nitrogen-intensive biological processes. In SCD, where erythrocyte lifespan is significantly shortened due to chronic hemolysis, the bone marrow is under constant pressure to replenish red blood cells. A negative nitrogen balance compromises the availability of amino acids—particularly those required for globin chain synthesis—thus limiting the capacity of the bone marrow to produce functional erythrocytes. The result is persistent or worsening anemia, even in the absence of overt clinical crises. Inadequate protein status may also impair the responsiveness to erythropoietin, further blunting effective erythropoiesis ²¹. Moreover, nitrogen imbalance adversely affects leukocyte function and immune surveillance. Immune cells, particularly lymphocytes and neutrophils, require adequate protein substrates to support proliferation, antibody production, cytokine synthesis, and cytotoxic activity. In SCD, where individuals already face increased susceptibility to infections due to functional asplenia and chronic inflammation, suboptimal nitrogen status can exacerbate immunodeficiency. This predisposes patients to more frequent and severe infections, leading to increased hospitalizations and prolonged disease flares ²².

Platelet function and coagulation dynamics may also be influenced by protein and nitrogen deficiencies. Platelets rely on structural proteins and enzymatic systems that are nitrogen-dependent. A compromised nitrogen pool may impair platelet aggregation and contribute to the dysregulation of the coagulation cascade—factors that play a role in the pathogenesis of vaso-occlusive crises. Additionally, the repair of endothelial damage, a key process in preserving vascular integrity in SCD, requires sufficient amino acids for collagen formation and other reparative mechanisms ²³. Nitrogen imbalance may also influence the redox status of sickle cell patients. Antioxidant enzymes such as glutathione peroxidase, superoxide dismutase, and catalase are protein-based and require nitrogen for their synthesis. In a state of nitrogen deficiency, the capacity to synthesize these protective enzymes may be diminished, leading to oxidative stress—a known aggravator of erythrocyte sickling and hemolysis. This creates a vicious cycle in which nitrogen imbalance worsens oxidative damage, which in turn accelerates hemolysis and protein turnover ²⁴. In pediatric SCD patients, nitrogen imbalance has been linked with impaired growth and delayed developmental milestones. These hematological and systemic deficiencies not only reflect poor protein-nutritional status but also impact the long-term prognosis of affected children. Poor hemoglobin levels, immune suppression, and slowed somatic growth cumulatively reduce quality of life and functional capacity, emphasizing the clinical urgency of addressing nitrogen balance ^25-26.

 

Clinical and Nutritional Interventions

Effective management of nitrogen imbalance in sickle cell disease (SCD) necessitates a multifaceted approach that integrates clinical care with targeted nutritional strategies. Due to the chronic catabolic state and elevated protein turnover associated with SCD, particularly during vaso-occlusive crises or infections, conventional nutritional recommendations often fall short of meeting the metabolic demands of these patients. Clinical and dietary interventions must therefore be proactive, personalized, and based on a comprehensive understanding of individual needs [27-29]. Clinically, routine assessment of nutritional status should be incorporated into standard care for SCD patients, including regular evaluations of serum protein levels, body mass index (BMI), and markers of nitrogen excretion, such as urinary urea nitrogen. Where feasible, indirect calorimetry and nitrogen balance studies may provide more accurate estimates of metabolic demand. In patients with evidence of nitrogen deficit, medical nutrition therapy should be initiated under the guidance of dietitians experienced in hematologic and metabolic disorders [30-32]. From a nutritional standpoint, increasing dietary protein intake is the cornerstone of restoring nitrogen balance. The recommended daily allowance (RDA) for protein may need to be significantly increased in SCD patients, particularly during periods of increased stress or recovery. High-biological-value proteins—such as those from eggs, dairy, lean meats, fish, and legumes—should be prioritized to ensure the supply of essential amino acids. Supplemental formulations containing branched-chain amino acids (BCAAs), glutamine, and arginine have also been studied for their role in promoting nitrogen retention and tissue repair, with promising but still emerging evidence ^33-34.

Micronutrient support plays a complementary role. Zinc, folate, and vitamin B12 are crucial for DNA synthesis, erythropoiesis, and immune function, all of which are nitrogen-dependent processes. Ensuring adequate intake of these nutrients can enhance the effectiveness of protein utilization and support hematopoietic function. Additionally, antioxidants such as vitamins C and E may reduce oxidative stress, indirectly lowering protein degradation and conserving nitrogen stores ³⁵. In severe or complicated cases—such as hospitalized patients with poor oral intake, malabsorption, or increased metabolic demands—enteral or parenteral nutrition may be required. These interventions must be carefully monitored to avoid complications such as refeeding syndrome or fluid overload. The choice of protein sources, the timing of delivery, and the balance of macronutrients should be tailored to the patient's clinical condition and recovery goals ³⁶. Importantly, education and counseling for patients and caregivers are vital components of any nutritional intervention. Empowering individuals with SCD and their families to understand the importance of dietary protein, hydration, and nutrient diversity can lead to better compliance and long-term improvements in health outcomes. Community-based programs and school feeding initiatives may also play a role in supporting nutritional sufficiency, particularly in low-resource settings where SCD is prevalent ³⁷.

Conclusion

Nitrogen balance is a fundamental determinant of hematological stability and overall health in individuals with sickle cell disease (SCD). The chronic metabolic demands imposed by hemolysis, inflammation, and tissue repair processes render patients particularly vulnerable to nitrogen deficits. When unaddressed, nitrogen imbalance exacerbates anemia, impairs immune function, delays growth and development, and diminishes the body's capacity to withstand oxidative and infectious stressors. These consequences underscore the importance of integrating nitrogen balance assessment and management into the comprehensive care of SCD patients. Nutritional strategies, including increased protein intake, targeted amino acid supplementation, and micronutrient support, can effectively restore nitrogen equilibrium and enhance clinical outcomes. Additionally, proactive clinical monitoring and individualized dietary planning are essential to ensure that metabolic demands are met across the disease spectrum—from childhood through adulthood, and during both steady-state and crisis periods.

Conflict of Interest: Author declares no potential conflict of interest with respect to the contents, authorship, and/or publication of this article.

Source of Support: Nil

Funding: The authors declared that this study has received no financial support.

Informed Consent Statement: Not applicable. 

Data Availability Statement: The data supporting in this paper are available in the cited references. 

Ethics approval: Not applicable.

References

1. Gupta A. Sickle Cell Anemia and Related Hemoglobinopathies. InDecision Making Through Problem Based Learning in Hematology: A Step-by-Step Approach in patients with Anemia 2024: 269-289. Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-8933-1_21

2. Hassan MS, Nasrin T, Mahalka A, Hoque M, Ali S. A perspective on the genesis, diagnostics, and management of sickle cell disease. Egyptian Journal of Medical Human Genetics. 2024; 25(1):150. https://doi.org/10.1186/s43042-024-00623-1

3. Rajput HS, Kumari M, Talele C, Sajan C, Saggu V, Hadia R. Comprehensive Overview Of Sickle Cell Disease: Global Impact, Management Strategies, And Future Directions. Journal of Advanced Zoology. 2024; 45(1). https://doi.org/10.53555/jaz.v45i1.3390

4. Obeagu EI. Role of Autophagy in Modulating Oxidative Stress in Sickle Cell Disease: A Narrative Review. Int. J. Curr. Res. Chem. Pharm. Sci. 2024;11(8):38-46. https://doi.org/10.23880/hij-16000247

5. Obeagu EI. Redox Regulation of Hemoglobin in Sickle Cell Disease: A Review. Int. J. Curr. Res. Chem. Pharm. Sci. 2024;11(8):13-9.

6. Obeagu EI, Bunu UO, Obeagu GU, Habimana JB. Antioxidants in the management of sickle cell anaemia: an area to be exploited for the wellbeing of the patients. Int Res Med Health Sci. 2023 Sep 11;6:12-7.

7. Xiao R, Li L, Zhang Y, Fang L, Li R, Song D, Liang T, Su X. Reducing carbon and nitrogen loss by shortening the composting duration based on seed germination index (SCD@ GI): feasibilities and challenges. Science of The Total Environment. 2024:172883. https://doi.org/10.1016/j.scitotenv.2024.172883 PMid:38697528

8. Lin W, Lv X, Wang Q, Li L, Zou G. Nitrogen concentration dependent optical defects transition in single crystal diamond through low pressure high temperature annealing. Vacuum. 2025:114329. https://doi.org/10.1016/j.vacuum.2025.114329

9. Wood KC, Granger DN. Sickle cell disease: role of reactive oxygen and nitrogen metabolites. Clinical & Experimental Pharmacology & Physiology. 2007 Sep 1;34(9). https://doi.org/10.1111/j.1440-1681.2007.04639.x PMid:17645642

10. Dijkmans T, Djokic MR, Van Geem KM, Marin GB. Comprehensive compositional analysis of sulfur and nitrogen containing compounds in shale oil using GC× GC-FID/SCD/NCD/TOF-MS. Fuel. 2015; 140:398-406. https://doi.org/10.1016/j.fuel.2014.09.055

11. Muehle M, Asmussen J, Becker MF, Schuelke T. Extending microwave plasma assisted CVD SCD growth to pressures of 400 Torr. Diamond and Related Materials. 2017; 79:150-163. https://doi.org/10.1016/j.diamond.2017.09.013

12. Obeagu EI, Obeagu GU. Immunization strategies for individuals with sickle cell anemia: A narrative review. Medicine. 2024; 103(38):e39756. https://doi.org/10.1097/MD.0000000000039756 PMid:39312357 PMCid:PMC11419550

13. Obeagu EI. Strategies for reducing child mortality due to sickle cell disease in Uganda: a narrative review. Annals of Medicine and Surgery.:10-97.

14. Obeagu EI. Erythropoeitin in sickle cell anaemia: a review. International Journal of Research Studies in Medical and Health Sciences. 2020;5(2):22-8. https://doi.org/10.22259/ijrsmhs.0502004

15. Obeagu EI, Obeagu GU. Malnutrition in sickle cell anemia: prevalence, impact, and interventions: a review. Medicine. 2024 May 17;103(20):e38164. https://doi.org/10.1097/MD.0000000000038164 PMid:38758879 PMCid:PMC11098235

16. Quemada M, Delgado A, Mateos L, Villalobos FJ. Nitrogen fertilization I: The nitrogen balance. InPrinciples of agronomy for sustainable agriculture 2024: 377-401. Cham: Springer International Publishing. https://doi.org/10.1007/978-3-031-69150-8_26

17. Krug EC, Winstanley D. The need for comprehensive and consistent treatment of the nitrogen cycle in nitrogen cycling and mass balance studies: I. Terrestrial nitrogen cycle. Science of the total environment. 2002; 293(1-3):1-29. https://doi.org/10.1016/S0048-9697(01)01133-0 PMid:12109464

18. Zhang CC, Zhou CZ, Burnap RL, Peng L. Carbon/nitrogen metabolic balance: lessons from cyanobacteria. Trends in plant science. 2018; 23(12):1116-1130. https://doi.org/10.1016/j.tplants.2018.09.008 PMid:30292707

19. Enwonwu CO, Xu XX, Turner E. Nitrogen metabolism in sickle cell anemia: free amino acids in plasma and urine. The American journal of the medical sciences. 1990; 300(6):366-371. https://doi.org/10.1097/00000441-199012000-00005 PMid:2264574

20. Borel MJ, Buchowski MS, Turner EA, Peeler BB, Goldstein RE, Flakoll PJ. Alterations in basal nutrient metabolism increase resting energy expenditure in sickle cell disease. American Journal of Physiology-Endocrinology and Metabolism. 1998; 274(2):E357-364. https://doi.org/10.1152/ajpendo.1998.274.2.E357 PMid:9486169

21. Jackson AA. The use of stable isotopes to study nitrogen metabolism in homozygous sickle cell disease. InGenetic factors in nutrition. 1984: 297-315. Academic Press, New York. https://doi.org/10.1016/B978-0-12-715950-8.50024-X PMCid:PMC7131065

22. Schnog JJ, Jager EH, van der Dijs FP, Duits AJ, Moshage H, Muskiet FD, Muskiet FA. Evidence for a metabolic shift of arginine metabolism in sickle cell disease. Annals of Hematology. 2004; 83:371-375. https://doi.org/10.1007/s00277-004-0856-9 PMid:15054669

23. Darghouth D, Koehl B, Madalinski G, Heilier JF, Bovee P, Xu Y, Olivier MF, Bartolucci P, Benkerrou M, Pissard S, Colin Y. Pathophysiology of sickle cell disease is mirrored by the red blood cell metabolome. Blood, The Journal of the American Society of Hematology. 2011; 117(6):e57-66. https://doi.org/10.1182/blood-2010-07-299636 PMid:21135259

24. Morris CR, Kato GJ, Poljakovic M, Wang X, Blackwelder WC, Sachdev V, Hazen SL, Vichinsky EP, Morris SM, Gladwin MT. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. Jama. 2005; 294(1):81-90. https://doi.org/10.1001/jama.294.1.81 PMid:15998894 PMCid:PMC2065861

25. Zhou Y, Yu X, Nicely A, Cunningham G, Challa C, McKinley K, Nickel R, Campbell A, Darbari D, Summar M, Majumdar S. Amino acid signature during sickle cell pain crisis shows significant alterations related to nitric oxide and energy metabolism. Molecular genetics and metabolism. 2022; 137(1-2):146-152. https://doi.org/10.1016/j.ymgme.2022.08.004 PMid:36030599

26. D'Alessandro A, Nouraie SM, Zhang Y, Cendali F, Gamboni F, Reisz JA, Zhang X, Bartsch KW, Galbraith MD, Espinosa JM, Gordeuk VR. Metabolic signatures of cardiorenal dysfunction in plasma from sickle cell patients as a function of therapeutic transfusion and hydroxyurea treatment. Haematologica. 2023; 108(12):3418. https://doi.org/10.3324/haematol.2023.283288 PMid:37439373 PMCid:PMC10690926

27. Obeagu EI, Prajapati SK, Maurya SD, Maternal Anemia in the Context of Infectious Diseases during Pregnancy: A Review, International Journal of Medical Sciences and Pharma Research, 2025;11(1):8-13 https://doi.org/10.22270/ijmspr.v11i1.134

28. Obeagu EI, Chukwu PH. Inclusive Healthcare Approaches for HIV-Positive Sickle Cell Disease Patients: A Review. Current Research in Biological Sciences. 2025;1(1):01-8.

29. Obeagu EI, Obeagu GU. Managing gastrointestinal challenges: diarrhea in sickle cell anemia. Medicine. 2024; 103(18):e38075. https://doi.org/10.1097/MD.0000000000038075 PMid:38701274 PMCid:PMC11062666

30. Obeagu EI, Obeagu GU. Living with sickle cell in Uganda: A comprehensive perspective on challenges, coping strategies, and health interventions. Medicine. 2024 Dec 20;103(51):e41062. https://doi.org/10.1097/MD.0000000000041062 PMid:39705436 PMCid:PMC11666137

31. Obeagu EI, Adias TC, Obeagu GU. Advancing life: innovative approaches to enhance survival in sickle cell anemia patients. Annals of Medicine and Surgery. 2024; 86(10):6021-6036. https://doi.org/10.1097/MS9.0000000000002534 PMid:39359845 PMCid:PMC11444627

32. Bell V, Varzakas T, Psaltopoulou T, Fernandes T. Sickle cell disease update: new treatments and challenging nutritional interventions. Nutrients. 2024; 16(2):258. https://doi.org/10.3390/nu16020258 PMid:38257151 PMCid:PMC10820494

33. Khan SA, Damanhouri G, Ali A, Khan SA, Khan A, Bakillah A, Marouf S, Al Harbi G, Halawani SH, Makki A. Precipitating factors and targeted therapies in combating the perils of sickle cell disease---A special nutritional consideration. Nutrition & metabolism. 2016; 13:1-2. https://doi.org/10.1186/s12986-016-0109-7 PMid:27508000 PMCid:PMC4977632

34. Patel S, Patel R, Mukkala SR, Akabari A. Emerging therapies and management approaches in sickle cell disease (SCD): A critical review. Journal of Phytonanotechnology and Pharmaceutical Sciences. 2023; 3(3):1-1. https://doi.org/10.54085/jpps.2023.3.3.3

35. Obeagu EI, Prajapati SK, Maurya SD, Anemia in Pregnancy: Exploring Non-Iron Deficiency Causes, International Journal of Medical Sciences and Pharma Research, 2025;11(1):1-7 https://doi.org/10.22270/ijmspr.v11i1.130

36. Boma PM, Kaponda AA, Panda J, Bonnechère B. Enhancing the management of pediatric sickle cell disease by integrating functional evaluation to mitigate the burden of vaso-occlusive crises. Journal of Vascular Diseases. 2024; 3(1):77-87. https://doi.org/10.3390/jvd3010007

37. Obeagu EI, Chukwu PH. Inclusive Healthcare Approaches for HIV-Positive Sickle Cell Disease Patients: A Review. Current Research in Biological Sciences. 2025;1(1):01-8.